Description of the drug
The drug with the commercial name Entyvio contains the active substance vedolizumab. It is supplied in the form of a vial from the manufacturer TAKEDA. Vedolizumab belongs to support drugs and is intended to improve the condition of patients with certain diseases.
Indications for use
Entyvio is intended for people who need additional support to improve the body's condition in case of certain diseases.
Advantages
- Convenience of use in vial form
- Support for the body in case of diseases
Effectiveness in improving the condition of patients
Application
The drug is recommended to be used according to the doctor's instructions. Usually, it is taken to improve the body's condition under certain conditions.
Who is suitable
The drug is suitable for individuals who need support to improve their condition in case of diseases.
Search queries
This drug is also searched for as: vedolizumab, Entyvio vial, TAKEDA vedolizumab.
Characteristics
Chemical name
Ведолизумаб
Commercial name
Энтивио
Dosage
300 мг
Number
1
Release form
Флакон